BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 28796729)

  • 1. Postoperative Chemoradiotherapy After Local Resection for High-Risk T1 to T2 Low Rectal Cancer: Results of a Single-Arm, Multi-Institutional, Phase II Clinical Trial.
    Sasaki T; Ito Y; Ohue M; Kanemitsu Y; Kobatake T; Ito M; Moriya Y; Saito N
    Dis Colon Rectum; 2017 Sep; 60(9):914-921. PubMed ID: 28796729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transanal endoscopic microsurgery for residual rectal cancer (ypT0-2) following neoadjuvant chemoradiation therapy: another word of caution.
    Perez RO; Habr-Gama A; Lynn PB; São Julião GP; Bianchi R; Proscurshim I; Gama-Rodrigues J
    Dis Colon Rectum; 2013 Jan; 56(1):6-13. PubMed ID: 23222274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local excision of distal rectal cancer: an update of cancer and leukemia group B 8984.
    Greenberg JA; Shibata D; Herndon JE; Steele GD; Mayer R; Bleday R
    Dis Colon Rectum; 2008 Aug; 51(8):1185-91; discussion 1191-4. PubMed ID: 18536973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological Outcomes of Lateral Pelvic Lymph Node Metastasis in Rectal Cancer Treated With Preoperative Chemoradiotherapy.
    Ishihara S; Kawai K; Tanaka T; Kiyomatsu T; Hata K; Nozawa H; Morikawa T; Watanabe T
    Dis Colon Rectum; 2017 May; 60(5):469-476. PubMed ID: 28383446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
    Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
    Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate radical resection after local excision of rectal cancer: an oncologic compromise?
    Hahnloser D; Wolff BG; Larson DW; Ping J; Nivatvongs S
    Dis Colon Rectum; 2005 Mar; 48(3):429-37. PubMed ID: 15747069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
    Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
    Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
    Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
    Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival after local excision for T1 carcinoma of the rectum.
    Nascimbeni R; Nivatvongs S; Larson DR; Burgart LJ
    Dis Colon Rectum; 2004 Nov; 47(11):1773-9. PubMed ID: 15622568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal Endoscopic Microsurgery for Early Rectal Cancer: A Single-Center Experience.
    O'Neill CH; Platz J; Moore JS; Callas PW; Cataldo PA
    Dis Colon Rectum; 2017 Feb; 60(2):152-160. PubMed ID: 28059911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Distal Resection Margin of ≤1 mm and Rectal Cancer Recurrence After Sphincter-Preserving Surgery: The Role of a Positive Distal Margin in Rectal Cancer Surgery.
    Zeng WG; Liu MJ; Zhou ZX; Wang ZJ
    Dis Colon Rectum; 2017 Nov; 60(11):1175-1183. PubMed ID: 28991082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II Trial.
    Marco MR; Zhou L; Patil S; Marcet JE; Varma MG; Oommen S; Cataldo PA; Hunt SR; Kumar A; Herzig DO; Fichera A; Polite BN; Hyman NH; Ternent CA; Stamos MJ; Pigazzi A; Dietz D; Yakunina Y; Pelossof R; Garcia-Aguilar J;
    Dis Colon Rectum; 2018 Oct; 61(10):1146-1155. PubMed ID: 30192323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
    Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small carcinomas involving less than one-quarter of the rectal circumference: local excision is still associated with a high risk of nodal positivity.
    Ferko A; Orhalmi J; Dusek T; Chobola M; Hovorkova E; Hadzi Nikolov D; Dolejs J
    Colorectal Dis; 2015 Oct; 17(10):876-81. PubMed ID: 25808035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
    Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
    Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiotherapy and total mesorectal excision surgery for locally advanced rectal cancer: correlation with rectal cancer regression grade.
    Wheeler JM; Dodds E; Warren BF; Cunningham C; George BD; Jones AC; Mortensen NJ
    Dis Colon Rectum; 2004 Dec; 47(12):2025-31. PubMed ID: 15657650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved outcomes for rectal cancer in the era of preoperative chemoradiation and tailored mesorectal excision: a series of 338 consecutive cases.
    Pacelli F; Sanchez AM; Covino M; Tortorelli AP; Bossola M; Valentini V; Gambacorta MA; Doglietto GB
    Am Surg; 2013 Feb; 79(2):151-61. PubMed ID: 23336654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laparoscopic Versus Open Lateral Lymph Node Dissection for Locally Advanced Low Rectal Cancer: A Subgroup Analysis of a Large Multicenter Cohort Study in Japan.
    Yamaguchi T; Konishi T; Kinugasa Y; Yamamoto S; Akiyoshi T; Okamura R; Ito M; Nishimura Y; Shiozawa M; Yamaguchi S; Hida K; Sakai Y; Watanabe M
    Dis Colon Rectum; 2017 Sep; 60(9):954-964. PubMed ID: 28796734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.